Biofilm cells have phenotypes distinct from planktonic cells, and this difference is reflected in greatest detail at the gene expression level. Detailed gene expression profiling comparisons, conducted in both
C. albicans and
A. fumigatus, have revealed substantial changes in gene expression between biofilm and planktonic cells
[22],
[26]. Changes in transcription factor expression is characteristic of
C. albicans biofilm formation in vitro and in vivo
[24]–
[26], suggesting biofilm formation to be a highly regulated process. Similarly, almost 50% of the predicted transcription factors of
A. fumigatus, including many with roles in asexual and sexual development, are upregulated in biofilms compared to planktonic cells.
Although biofilms are thought to include dormant cells, biofilms of
C. albicans and
A. fumigatus have increased expression of genes involved in protein synthesis. These genes encode ribosomal proteins, protein turnover, and translation factors as well as ribosomal proteins, indicating increased protein translation and ribosome production in biofilms to be a feature of biofilms
[22],
[25],
[26]. If indeed biofilm cells are nutrient limited, these particular gene expression features may optimize recycling of cellular constituents.
Upregulation of multi-drug resistance transporter genes is common to
A. fumigatus (
MDR1, MDR2, MDR4) and
C. albicans (
MDR1, CDR1, CDR2) biofilms in vitro
[22].
C. albicans MDR1 and
CDR2 are upregulated in in vivo biofilms, as is
PDR16, which is increased in fluconazole-resistant cells that overexpress
CDR1 and
CDR2
[25]. Phase dependency of these transporters exists in vivo for
C. albicans CDR1 and in
A. fumigatus for
MDR4
[25],
[27]. Additionally, ergosterol gene expression may account for increased drug resistance of biofilms. Genes involved in sterol biosynthesis are upregulated in
A. fumigatus and
C. albicans biofilms
[22],
[25],
[26]. Increases in
ERG gene expression as well as multi-drug resistance transporters has been correlated with increased azole resistance in
C. albicans patient isolate samples, though their contribution to biofilm-specific azole resistance has not been detected in mature biofilms (see
Text S1).
Increased expression of adherence genes is also a property of biofilm cells.
ALS1 is the most upregulated of the known adherence genes of
C. albicans under biofilm conditions. Garcia-Sanchez et al. (2004)
[26] highlight that the
ALS genes are differentially expressed in biofilms and have autonomous contributions in the biofilm transcriptome. Nett et al. (2009)
[25] observed differential expression of
ALS genes at different stages of biofilm formation and potential for overlap of function in vivo. A similar pattern of differential adhesin expression is seen in vitro in the
A. fumigatus biofilm environment
[22]. The inducing signal for biofilm adherence genes is clearly an area of interest as a basic biological question as well as a direction for prospective therapeutic development.
A significant number of primary metabolism genes, including those for amino acid synthesis, in particular sulfur amino acid biosynthesis, and nucleotide synthesis, are upregulated in
C. albicans biofilms in vitro
[24],
[26] and in vivo
[25], relative to in planktonic cells in vitro. Many are regulated by
GCN4, a transcriptional activator required for biofilm formation
[26]. Genes involved in amino acid metabolism are also upregulated in
A. fumigatus biofilms including amino acid permeases, transporters, and amino peptidases. Secondary metabolism gene upregulation is significant in
A. fumigatus biofilms, possibly due to upregulation of
LAEA, a secondary metabolism regulator
[22]. Altered metabolic gene expression may reflect nutrient limitation, but the rapid kinetics of induction (in
C. albicans at least
[24]) may reflect a different regulatory signal.
Many cell wall biogenesis genes are induced in the biofilm environment. Altered expression of genes for β-1,3 glucan synthesis and modification are features of in vivo
C. albicans biofilms including
FKS1,
BGL2, and
XOG1
[25]. Given the connection between the β-glucan pathway and biofilm matrix production, these may also contribute to ECM production. Nett et al. (2009)
[25] highlight downregulation of β-1,3 glucan degrading enzymes in 24-hour biofilms and suggest this functions in glucan conservation for matrix production. In contrast, altered expression of α- and β-1,3 glucan synthesis genes is not observed in
A. fumigatus biofilms. Although it is not directly reflected by the expression of polysaccharide synthase genes, the presence of α-1,3 glucan, galactosaminogalactan, and galactomannan in the mycelial extacellular matrix is correlated to the aerial growth of the mycelium of
A. fumigatus
[16]. Expression of more than 50% of cell wall genes investigated in
A. fumigatus is, however, altered in the biofilm habitat, including upregulation of the
ROD genes. Thus, these two organisms both restructure their cell surfaces in biofilms, though they may use different mechanisms to achieve that outcome.